|Articles|October 1, 2001

Tax relief and cuts can lead to business benefits

The disappearing surplus makes it unlikely that Congress will pass any significant tax cuts, especially tax cuts for businesses, before 2002. Surprisingly, the tax bill passed early in 2001 and "hyped" as being primarily for individual taxpayers, offers relief for many urologists and their practices.


Related to this article

Rethinking Testosterone Therapy After the FDA Label Revisions
Expert urologists examine how TRAVERSE data and an FDA expert panel prompted proposed label revisions for testosterone therapy as well as what narrowed cardiovascular, prostate, and age-related restrictions mean for evaluating and treating testosterone deficiency.